BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 12110385)

  • 1. Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation.
    Ficarra R; Tommasini S; Raneri D; Calabrò ML; Di Bella MR; Rustichelli C; Gamberini MC; Ficarra P
    J Pharm Biomed Anal; 2002 Aug; 29(6):1005-14. PubMed ID: 12110385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Investigation of Hesperetin-7-
    Kapoor MP; Moriwaki M; Minoura K; Timm D; Abe A; Kito K
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and spectroscopic studies of an inclusion complex of adenine with beta-cyclodextrin in solution and in the solid state.
    Hao X; Liang C; Jian-Bin C
    Analyst; 2002 Jun; 127(6):834-7. PubMed ID: 12146920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
    Pralhad T; Rajendrakumar K
    J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state.
    Bayomi MA; Abanumay KA; Al-Angary AA
    Int J Pharm; 2002 Aug; 243(1-2):107-17. PubMed ID: 12176299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
    Patel SG; Rajput SJ
    AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization, inclusion mode, phase-solubility and in vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug.
    Aloisio C; Gomes de Oliveira A; Longhi M
    Drug Dev Ind Pharm; 2014 Jul; 40(7):919-28. PubMed ID: 23627444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced pharmacological efficacy of sumatriptan due to modification of its physicochemical properties by inclusion in selected cyclodextrins.
    Paczkowska M; Mizera M; Sałat K; Furgała A; Popik P; Knapik-Kowalczuk J; Krause A; Szymanowska-Powałowska D; Fojud Z; Kozak M; Paluch M; Cielecka-Piontek J
    Sci Rep; 2018 Nov; 8(1):16184. PubMed ID: 30385844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.
    Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR
    AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of inclusion complex of epothilone A with cyclodextrins.
    Xiao CF; Li K; Huang R; He GJ; Zhang JQ; Zhu L; Yang QY; Jiang KM; Jin Y; Lin J
    Carbohydr Polym; 2014 Feb; 102():297-305. PubMed ID: 24507285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions.
    Wang D; Li H; Gu J; Guo T; Yang S; Guo Z; Zhang X; Zhu W; Zhang J
    J Pharm Biomed Anal; 2013 Sep; 83():141-8. PubMed ID: 23732534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion complexation of nimesulide with beta-cyclodextrins.
    Vavia PR; Adhage NA
    Drug Dev Ind Pharm; 1999 Apr; 25(4):543-5. PubMed ID: 10194611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations.
    Villaverde J; Morillo E; Pérez-Martínez JI; Ginés JM; Maqueda C
    J Agric Food Chem; 2004 Feb; 52(4):864-9. PubMed ID: 14969543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.
    Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ
    Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel/dimethyl-β-cyclodextrin inclusion complexes: preparation,
    Giri BR; Lee J; Lim DY; Kim DW
    Drug Dev Ind Pharm; 2021 Feb; 47(2):319-328. PubMed ID: 33576707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
    Hu L; Zhang H; Song W; Gu D; Hu Q
    Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of host-guest complexes of β-cyclodextrin and perfluorooctanoic acid.
    Karoyo AH; Borisov AS; Wilson LD; Hazendonk P
    J Phys Chem B; 2011 Aug; 115(31):9511-27. PubMed ID: 21688796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.